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BACKGROUND AND PURPOSE: To describe the results of transvenous embolizations of cavernous dural
arteriovenous fistua (cDAVF) with an emphasis on identifying the incidence, characteristics, and
management strategies associated with the complications of transvenous embolization of cDAVFs.
METHODS: Fifty-six consecutive patients who were treated by transvenous embolization for cDAVFs
were reviewed. The approach routes, angiographic results, complications, and clinical outcome were
assessed.
RESULTS: Retrograde inferior petrosal sinus (n  36), transfacial vein (n  7), transcontralateral
intercavernous sinus (n  4), and direct superior ophthalmic vein (n  3) approaches were used.
Angiographic results showed complete occlusion (n  29), nearly complete occlusion (n  13), and
incomplete occlusion (n  14). Complications associated with the procedures were cranial nerve palsy
(n 6), venous perforation (n 3), and brain stem congestion (n 2). The cranial nerve signs resolved
with conservative treatment. Venous perforations were managed by coil embolizations at the site of
the tear with no significant neurologic sequelae. One case of brain stem congestion resulted in
hemiplegia after conservative treatment. The other case showed venous congestion as a result of
rerouting of the shunted flow after venous embolization that was successfully managed by covered
stent deployment for occlusion of the residual feeders. Clinical follow-up data were available in 46
patients. Complete resolution or improvement of symptoms was seen in 42 patients (91%).
CONCLUSIONS: Cavernous DAVFs may be effectively treated by transvenous embolization. However,
the procedure can be associated with various complications, some of which can potentially result in
significant morbidity. Prompt diagnosis of the complications with appropriate management strategies
is mandatory for a safe procedure.
Dural arteriovenous fistulas (DAVFs) are abnormal arterio-venous shunts developing on the dura mater, usually
within or near the walls of a dural sinus.1 The transverse sig-
moid sinus and the cavernous sinus are known to be the most
frequent sites of occurrence; the cavernous sinus is the most
frequent in the Asian literature.2-4 The symptoms of these le-
sions depend on the location of the shunt, the type of venous
drainage, and the flow characteristics.1 Cavernous DAVFs
(cDAVFs)may show signs of orbital hypertension—which in-
clude glaucoma, pulsatile exophthalmos, chemosis, conjunc-
tival injection, and episcleral venous dilation—central ner-
vous system symptoms, or bruit according to the venous
drainage pattern.5,6
The decision to treat cDAVFs dependsmostly on the drain-
age pattern and the symptoms of the lesion. Some of these
lesions may even regress spontaneously.7-9 However, DAVFs
that are associated with persistent cortical venous drainage are
known to yield an annual mortality rate of 10.4%.10 Thus,
higher risk lesions associated with cortical venous drainage,
progressive visual loss, neurologic deficits, hemorrhage, and
cases presenting with intolerable diplopia, severe headache,
and severe cosmetic disfigurement justify endovascular inter-
vention.11-13 The treatment options for cDAVFs includeman-
ual compression of the ipsilateral carotid artery, transarterial
embolization of feeder vessels, and transvenous embolization.
The manual carotid compression may be performed in pa-
tients with a benign type of cDAVF. This maneuver is simple
and allows thrombus formation in the cavernous sinus by ar-
terial and venous occlusion.14 Transarterial feeder vessel em-
bolizations may be performed for the cDAVF lesion but are
frequently inadequate for definitive treatment. Some lesions
derivemeningeal supply from branches of the intracranial cir-
culation that cannot be accessed or embolized safely. In some
cases, a plethora of external carotid artery meningeal supply
may not be satisfactorily accessed.5
Transvenous embolization is generally considered to be an
effective method of treatment for cDAVFs.5 Since the initial
reports of transvenous embolization for carotid cavernous fis-
tulas, improvement in endovascular techniques and materials
has allowed alternative choice of routes in addition to the in-
ferior petrosal sinus (IPS) for navigation of the microcatheter
and microwire into the targeted cavernous sinus.15,16 How-
ever, there are potential complications associated with this
procedure, and there is a lack of detailed information concern-
ing the incidence, manifestations, and management of such
complications in the literature.
In this study, we reviewed a relatively large homogenous
group of cDAVFs treated in a single institution. The purpose
of this study was to describe the results of transvenous embo-
lization of cDAVF with an emphasis on identifying the inci-
dence, characteristics, and management strategies associated
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with the complications of transvenous embolizations of
cDAVFs.
Materials and Methods
We conducted a retrospective analysis of patients who underwent
transvenous embolizations for cDAVF between January 1997 and
September 2005. The imaging findings and medical records of 56
consecutive patients were reviewed. The approach routes, angio-
graphic results, complications, and clinical outcome were assessed.
Institutional review board approval was obtained for this retrospec-
tive study with waiver of informed consent.
Bilateral selective internal carotid artery (ICA), external carotid
artery, and common carotid artery angiographywere performed in all
patients for assessment of the feeding arteries, the fistula sites, and the
venous drainage patterns. Patients with higher risk drainage patterns,
such as cortical venous drainage, worsening of visual acuity, or intol-
erable symptoms, were selected for endovascular treatment. In gen-
eral, the embolization procedures were performed under local anes-
thesia, and the transvenous approach was initially attempted through
the ipsilateral IPS regardless of its angiographic patency. A 5F guiding
catheter was navigated to the internal jugular vein, and a microcath-
eter with a microwire was navigated coaxially to the cavernous sinus
via the IPS. In some cases, a diagnostic angiographic catheter was
positioned in the external carotid artery to delineate the target site for
occlusion with the road-mapping technique.
If the ipsilateral IPS approach was not successful, the contralateral
intercavernous sinus, facial vein, or the direct superior ophthalmic
vein (SOV) routes were also used. For the direct SOV approach, the
vessel was exposed by the neurosurgeon and then punctured. The
microguidewire was then carefully introduced and advanced to the
cavernous portion, followed by the microcatheter.
All transvenous embolizations were performed with fibered
and/or electrically detachable coils under real-time digital subtraction
fluoroscopic mapping. Adjunctive transarterial embolizations were
also performed with polyvinyl alcohol (PVA) particles or n-butyl-
cyanoacrylate (n-BCA) in cases of remnant shunt or failed trans-
venous approach.
Angiographic complete occlusion was defined as complete occlu-
sion of the shunt, nearly complete occlusion as small residual stagnant
shunt that was considered likely to thrombose, and incomplete occlu-
sion as the presence of residual shunt. Complete and nearly complete
occlusions were considered successful angiographic results.
The patients were generally followed by clinical evaluations on a
2–3 month basis and in between upon changes or deterioration in
symptoms. Additional imaging studies such as brain CT or MR were
performed during the follow-up period in complicated cases. Angio-
graphic reevaluation was performed if changes or deterioration of
symptoms believed to be related to the DAVF had occurred.
Clinical improvement was defined as cure or improvement of the
symptoms related to the lesion, no improvement as no changes or
aggravation of symptoms, and recurrence as newly developed symp-
toms related to the lesion during follow-up.
Results
The characteristics of the patients are summarized in Table 1.
Overall, the transvenous approach to the cavernous lesion
site was successful in 50 cases (89.3%). Ipsilateral IPS ap-
proach was successful in 36 cases (64%). Other accessible ve-
nous approaches were also used, including the transcontralat-
eral intercavernous sinus (n 4), and the facial vein (n 7).
Direct surgical SOV puncture approach was also performed in
3 cases. Adjunctive transarterial embolizations for residual
shunts after transvenous embolizations were performed in 11
cases (19.6%). Target site access through any available venous
route was unsuccessful in 6 cases (10.7%), and transarterial
embolizations using PVA and n-BCA were performed for
these cases. Angiographic complete (n 29) and nearly com-
plete (n  13) occlusions were achieved in 29 and 13 cases,
respectively, for an angiographic success rate of 75% (n 42).
Clinical follow-up data were available in 46 patients (mean 13
months; range, 1 week to 7 years). Complete resolution or
improvement of symptomswere seen in 42 patients (91%), no
improvement of symptoms in 2 patients, and recurrent symp-
toms in 2 patients.
Overall, complications associated with the procedure were
observed in 11 cases (19.6%). The most common complica-
tion associated with the procedure was cranial nerve palsy
(n  6, 10.7%) (Table 2). Abducens nerve palsy (n  5) was
the most common pattern. In general, the symptoms relieved
within a few days to weeks with conservative treatment. How-
ever, 1 patient complained of mild residual diplopia as a result
of abducens nerve palsy after 42 months of follow-up.
A case of severe trigeminal neuralgia was also observed in
which the patient complained of severe ipsilateral upper
toothache during the venous coil embolization procedure.
The patient recovered from the pain after 3 days of conserva-
tive analgesic treatment.
The second most common complication associated with
the transvenous embolization procedure was venous perfora-
tion (n 3, 5.4%). The perforations occurred during careful
navigation with the microwire and microcatheter in the oc-
cluded dural sinuses or multicompartmented cavernous si-
nus. The sites of perforations were the IPS (n  1) and the
Table 1: Characteristics of patients and results of transvenous
embolizations
Characteristics Incidence (%)
Age (years) 30–73; mean, 57
Sex
Male 11 (20)
Female 45 (80)
Initial presenting symptoms
Chemosis 18 (32)
Exophthalmos 12 (21)
Orbital pain 19 (34)
Loss of visual acuity 7 (13)
Diplopia 19 (34)
Ptosis 7 (13)
Headache 12 (21)
Venous approach routes
Inferior petrosal sinus 36 (64)
Intercavernous sinus 4 (7)
Facial vein 7 (13)
Direct ophthalmic vein 3 (5)
Angiographic results
Complete 29 (52)
Nearly complete 13 (23)
Incomplete 14 (25)
Clinical outcome (n  46)
Improvement 42 (91)
No improvement 2 (4)
Recurred 2 (4)
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cavernous sinus (n  2). The perforations were identified by
opacification of the brain parenchymal outlines on slow care-
ful contrast injection through the microcatheters after sus-
pected venous tear. In all cases, the microcatheter was not
completely withdrawn from the suspected perforation site.
These perforated sites were embolized with coils. The patients
complained of headache and nausea but soon resolved during
follow-up without neurologic sequelae in all cases.
Venous congestion after transvenous coil embolizations
occurred in 2 cases (3.6%). In 1 case, the patient developed
dysarthria, decreased gag reflex, and hemiparesis on the
evening of the treatment. Follow-upCT and repeat angiogram
revealed venous congestion of the posterior fossa. These
symptoms were managed conservatively, but the patient did
not recover from the hemiparesis, resulting in permanent
morbidity (follow-up, 7 years). The other patient (Fig 1) un-
derwent aggressive eradication of the small residual meningo-
hypophyseal feeders with covered stent grafts (Jomed Interna-
tional, Helsingborg, Sweden; 3.5/12 mm [right ICA] and 4/16
mm [left ICA]) after 3 days of antiplatelet premedication. The
patient was placed on aspirin (Astrix; 100 mg/day for 3
months) and clopidogrel (Plavix; 75mg/day indefinitely) after
Table 2: Characteristics of cranial nerve palsy caused by transvenous embolizations of the cavernous sinus
Sex/Age
Cranial
Nerve
IPS
Occlusion Route Materials
DSA
Outcome
Management of
Complications Outcome
F/46 V No Ipsi CS Plat (1) Incomplete Symptomatic Improved
Tungst (3)
M/65 VI No Ipsi CS Tungst (4) Incomplete Symptomatic Improved
F/58 VI Yes Ipsi CS Torn (5) Complete Symptomatic Mild residue
Plat (22)
Tungst (12)
F/69 VI No InterCS Tungst (9) Incomplete Symptomatic Improved
Plat (10)
F/30 VI No Ipsi CS TAE DCS (1) Complete Symptomatic Improved
Torn (18)
M/52 VI No Ipsi CS Trufill (13) Complete Symptomatic Improved
Torn (2)
Note:—IPS indicates inferior petrosal sinus; Ipsi, ipsilateral; CS, cavernous sinus; InterCS, intercavernous sinus; Plat, platinum coil; Tungst, tungsten coil; Torn, tornado coil; DCS, detachable
coil system; TAE, transarterial embolization; DSA, digital subtraction angiography.
Fig 1. A 60-year-old man presented with symptoms of decreased visual acuity, exophthalmos, and chemosis of the left eye
of 1 month’s duration.
A, Initial left ICA angiogram revealed an arteriovenous shunt at the left cavernous sinus with drainage into the superior
ophthalmic and inferior ophthalmic veins.
B, Transvenous coil embolization of the left cavernous sinus was performed via a left SOV approach, resulting in nearly
complete occlusion of the target sinus with slow but stagnant flow in the anterior pontomesencephalic veins (arrows).
C, Fluid-attenuated inversion recovery images of the patient after he developed mild dysarthria shows congestion of the brain
stem. Bilateral graft stents were deployed for occlusion of the residual meningohypophyseal feeders.
D, Poststent left ICA angiogram shows complete occlusion of the residual shunt.
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the treatment. The patient’s symptoms showed resolution,
and a conventional angiogram at 2-month follow-up revealed
persistent occlusion of the meningohypophyseal feeders with
patent bilateral stent grafts. Small reopening of the left middle
meningeal and artery of foramen rotundum feeders were suc-
cessfully embolized with liquid coil, n-BCA, and PVA. The
patient remained symptom-free after 8 months of follow-up.
Discussion
The results of this study show the efficacy of transvenous em-
bolizations for cDAVF in a large single series consisting of 56
cases. In addition, the incidence, characteristics, and manage-
ment strategies for complications associated with the proce-
dure have been presented.
The results of our study show that the transvenous access of
the target sinus was successful in 89% (n  50) of the cases.
The ipsilateral IPS selection was successful in 64% (n 36) of
cases. Other routes of navigation included the contralateral
cavernous sinus (7%, n 4), facial vein (13%, n 7), and the
SOV after surgical exposure (5%, n  3). The major routes
available for access to the cavernous sinus include: anteriorly,
the SOV and facial vein; superiorly, superficialmiddle cerebral
vein and sphenoparietal sinus; posteriorly, the petrosal sinus-
es; and inferiorly, the pterygoid plexus.17–21 Detailed knowl-
edge of the anatomy in addition to new endovascular equip-
ment suitable for navigation into small connecting channels is
essential for a successful treatment. Using this multichannel
approach, we were able to achieve complete or nearly com-
plete occlusion of the fistula in 75% (n  29 and 13, respec-
tively) with cure or improvement of symptoms in 91% (n 
42) on clinical follow-up. These results seem compatible with
other smaller series that had reported similar anatomic and
clinical cure rates of 71%–89% and 77%–96% and show the
efficacy of transvenous embolizations for cDAVFs.13,22-24
A few articles are available on the complications of trans-
venous embolization of cDAVF. Most are case reports or
small, heterogenous case series with a limited number of com-
plications.12,13,22,23,25-28 From a single center experience of 56
cases of transvenous cDAVF, we were able to identify the in-
cidence of various complications, characteristics, and the
management strategy.
The total incidence of complications associated with the
procedure was high (19.6%, n  11); however, most were
transient morbidities. Only a single case (1.8%) showed seri-
ous permanent deficit. The low incidence of permanent mor-
bidity despite the high incidence of total number of complica-
tions may be attributed to the vigilant detection and
management of the complications.
Six cases (10.7%) showed newly developed cranial nerve
signs after transvenous coil embolizations. The reason for cra-
nial nerve signs after transvenous embolization may be due to
progressive thrombosis of the cavernous sinus, mass effect by
the coil, and direct injury of the nerve by the coil ormicrowire/
microcatheter.23,29 In our series, the mean number of coils
used for embolization was 16.7 (range; 4–37 coils). Overpack-
ing of the cavernous sinus may have been a cause of the tran-
sient cranial nerve symptoms in most cases; however, para-
doxical worsening as a result of thrombosis of the cavernous
sinusmay be have been the cause in the 2 cases embolized with
only 4 coils. The reason for abducens nerve predilection is
unclear but may be because the occulomotor, trochlear, oph-
thalmic, and maxillary nerves are usually located in the lateral
wall of the cavernous sinus, whereas the abducens nerve is
located just lateral to the internal carotid artery. This anatomic
disposition may allow further vulnerability of the abducens
nerve to the stretching andmass effects of the coil or thrombus
within the sinus.30 Even though permanent deficits have been
reported, the management of these complications by conser-
vative analgesics and steroid therapy resulted in good
outcome.23
The rate of venous perforations (5.4%, n 3) in our series
seems to be higher than any in other case series.12,13,22,23 In the
other case series, newly developed subarachnoid hemorrhage
after transvenous embolization may have been due to unrec-
ognized venous perforation during the procedure.13,23,28 All
cases of venous perforations occurred during careful blind
navigation in the occluded sinuses. The results of our study
show that perforations can occur despite use of supple mi-
crowires and microcatheters. The hemodynamic stresses of
the shunted arterial flow leaking into the subdural/subarach-
noid spacesmay become a potential source of significantmor-
bidity if undetected or untreated. Direct surgical exposure and
obliteration of the perforation with n-BCA has been reported
formanagement of such complications.28However, according
to our series, immediate recognition and coil embolization at
the site of perforation, followed by occlusion of the arterio-
venous shunt to reduce the hemodynamic stress, seem to be
sufficient for management of such complications.
Two cases (3.6%) of venous congestion developed after
transvenous embolization of the cavernous sinus. Other re-
ports have shown rare cases of brain stem congestion in
cDAVF caused by shunted flow into the posterior fossa.25,31
Venous congestion by rerouting to the pontomesencephalic
veins occurred after coil embolization in our cases, despite
nearly complete occlusions of the shunts after embolization.
Such venous rerouting is a known complication in cases of
transvenous embolization in other dural sinuses. It is impor-
tant to avoid simple trapping or partial embolization of the
involved dural sinus, because this can lead to diversion of
shunt flow into the normal cerebral venous pathways and ul-
timately result in conversion of the DAVF into amore danger-
ous and aggressive disease.5 However, transvenous coil embo-
lization of the complex and septated cavernous sinus may
sometimes be difficult and could result in unintended danger-
ous rerouting of the shunt. Because of the small caliber and the
unusual anatomy of the brain stem venous drainage in our 2
cases, recognition of such potential complicationwas difficult.
Both patients developed neurologic symptoms after the com-
pletion of the procedure. In the first case, these symptoms
were treated by conservative management resulting in perma-
nent morbidity. In the second case, however, the newly devel-
oped neurologic symptom was recognized early as a possible
sign of venous congestion. A repeat angiogram revealed flow
in the small feeders from bilateral meningohypophyseal
trunks that were diverted to the pontomesencephalic veins.
These feeders were considered to cause venous hypertension
and were aggressively occluded by deploying covered stents in
the ICA. Experience from the cardiology literature has shown
the efficacy of polytetrafluoroethylene (PTFE)-covered stents
in occlusion of coronary perforations and aneurysms.32-34 In
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our cases, these stents were effective in occluding the arterial
feeders arising from the ICAby providing amechanical barrier
and also in ameliorating the harmful consequences of brain
stem congestion. Stent thrombosis and restenosis after cov-
ered stent deployment are a major concern. Previous studies
have reported subacute thrombosis and restenosis rates of
5.7% and 24%–31.6%, respectively, after covered stent im-
plantation for coronary aneurysm, perforation, saphenous
vein graft, and in-stent restenosis.32,35,36 The restenosis rate
after covered stent deployment in nonatherosclerotic parent
vessels are unknown; however, the rates seem lower in cases of
native, noncomplicated coronary vessels.32,34 Therefore, the
future risk for stenosis or occlusion in our case of stent graft in
the nonatherosclerotic ICA may be more favorable. Although
antiplatelet medications contradict the objective of occluding
the shunt, we believe that prolonged medication is necessary
for prevention of thrombosis and stenosis of the stent site. In
addition, mid- and long-term angiographic evaluations are
necessary for detection of not only stent stenosis but also re-
opening of the feeder vessels.
Conclusion
Cavernous DAVFs presenting with higher risk pattern such as
cortical venous drainage and intolerable symptoms may be
effectively treated by transvenous embolization. However,
transvenous embolization of the cavernous sinus can be asso-
ciated with various complications, some of which can poten-
tially result in significant morbidity. Prompt diagnosis of the
complications with appropriate management strategies is
mandatory for a safe procedure.
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